Hazard communication: challenges in the pharmaceutical industry.
Several of the major regulations mandating hazard communication programs around the world are reviewed and their applicability to the pharmaceutical industry is discussed. Regulation distinctions that are key to compliance activities are highlighted.
Hayes
E P
EP
Bristol-Myers Squibb Pharmaceutical Group, New Brunswick, New Jersey 08903, USA.
D003142:Communication; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D015386:Hazardous Substances / Q000009:adverse effects; D006256:Hazardous Waste / Q000331:legislation & jurisprudence*; D006801:Humans; D009784:Occupational Diseases / Q000517:prevention & control*; D016272:Occupational Health / Q000331:legislation & jurisprudence*; D018570:Risk Assessment; D012308:Risk Management / Q000331:legislation & jurisprudence* / Q000379:methods; D014481:United States
D015386:Hazardous Substances; D006256:Hazardous Waste